Showing results (51-60 of 155) with videos related to
Sort By:
Pageof 16
FEBS Letters|September 1, 1986
Porcine tissue plasminogen activator. Immunoaffinity purification, structural properties and glycosylation patternG Pohl, H Jörnvall, P Kok, et al.European Journal of Biochemistry|August 15, 1986
Proteolytically induced variations in the enzymatic properties of tissue plasminogen activator. Activations, inactivations and reactivationsB Norrman, G Pohl, H Jörnvall, et al.Zentralblatt Fur Chirurgie|January 1, 1988
[Results following reduction mammoplasties. A comparison of selected surgical procedures]G Berge, G Pohl, B Berge, et al.Zentralblatt Fur Chirurgie|January 1, 1989
[Mammographic findings following reduction mammaplasty]C Buhtz, J Freitag, G Berge, et al.FEBS Letters|May 30, 1983
Differential proteolysis and evidence for a residue exchange in tissue plasminogen activator suggest possible association between two types of protein microheterogeneityH Jörnvall, G Pohl, N Bergsdorf, et al.Thrombosis and Haemostasis|March 4, 1991
Synergism between tissue-type plasminogen activator and a genetically engineered variant lacking the finger domain, the growth factor domain and the first kringle domainC Mattson, K Wikström, C Sterky, et al.European Journal of Biochemistry|December 30, 1987
Isolation and characterization of three different carbohydrate chains from melanoma tissue plasminogen activatorG Pohl, L Kenne, B Nilsson, et al.Journal of Pediatric Urology|March 30, 2017
In pursuit of the perfect penis: Hypospadias repair outcomesBrenton B Winship, H Gil Rushton, Hans G PohlUrology|November 24, 2019
Antibiotic Prophylaxis Prescribing Patterns of Pediatric Urologists for Children with Vesicoureteral Reflux and other Congenital Anomalies of the Kidney and Urinary TractRana F Hamdy, Hans G Pohl, Catherine S ForsterJournal of Pediatric Urology|May 23, 2018
Hyaluronidase to reduce a prolapsed incontinent ischemic ileovesicostomyPatrick T Gomella, Hans G Pohl, Aaron J KrillPageof 16